Skip to main content
Clinical Trials/ISRCTN55659103
ISRCTN55659103
Completed
未知

Congenital anomalies in children following maternal use of dydrogesterone or micronized progesterone as luteal support in infertile women: A retrospective, observational study

Institute of Reproductive Medicine0 sites6,298 target enrollmentJanuary 11, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Infertility, luteal phase support
Sponsor
Institute of Reproductive Medicine
Enrollment
6298
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2019
End Date
June 30, 2017
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 2\. Aged 21\-45 years
  • 3\. Primary and secondary infertility (e.g. ovulatory and hormonal disorders, fallopian tube obstruction, endometriosis and having partners with male factor infertility)

Exclusion Criteria

  • 1\. Adenomyosis
  • 2\. Congenital uterine anomalies
  • 3\. Uterine synechiae
  • 4\. Baseline FSH \>12 IU
  • 5\. Donor oocyte recipients
  • 6\. Gestational surrogates

Outcomes

Primary Outcomes

Not specified

Similar Trials